The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2020

Filed:

Mar. 14, 2014
Applicant:

Modernatx, Inc., Cambridge, MA (US);

Inventors:

William Joseph Issa, Roslindale, MA (US);

Joseph Louis Barberio, Watertown, MA (US);

John Grant Aunins, Cambridge, MA (US);

Noubar B. Afeyan, Lexington, MA (US);

Assignee:

ModernaTX, Inc., Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/02 (2006.01); C12N 15/10 (2006.01); G01N 30/96 (2006.01); B01D 15/36 (2006.01); G01N 30/88 (2006.01);
U.S. Cl.
CPC ...
C07H 21/02 (2013.01); B01D 15/363 (2013.01); C12N 15/101 (2013.01); G01N 30/96 (2013.01); G01N 2030/8827 (2013.01);
Abstract

The current landscape for preparative chromatographic RNA purification uses reversed phase HPLC, but this technique presents many issues with process scale up and ion exchange for preparative purification has only been used for short RNAs. The invention provides preparative purification of RNA (e.g., mRNA) using ion (e.g., anion) exchange chromatography that allows for separation of longer RNAs up to 10,000 nucleotides in length via a scalable method. This method avoids problems with current techniques by using low pressure chromatography that is agreeable with existing equipment in cGMP commercial facilities, that uses aqueous-bases solutions as the mobile phase (rather than flammable of greater than 10 mg RNA/mL resin (e.g., using larger pore sorbents, >500 Angstroms, that display greater mRNA binding capacities), and that yields desired RNA salt forms for downstream formulation with no additional manipulation necessary (unlike ion pair reverse phase techniques).


Find Patent Forward Citations

Loading…